ClinicalTrials.gg
RecruitingNCT07910149Updated Nov 2, 2026

Airway Ultrasound in Oncologic Maxillofacial Patients

An observational study in Head and Neck Cancer, sponsored by University Hospital Dubrava. Recruiting at 2 sites in Croatia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by University Hospital Dubrava · Observational

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational cohort study will evaluate ultrasound-based airway measurements in adult patients with oncologic maxillofacial disease undergoing surgery under general anesthesia. The distance from the skin to the epiglottis (DSE) and the distance from the skin to the hyoid bone (DSHB) will be measured using preoperative airway ultrasonography and compared with corresponding measurements obtained from clinically indicated preoperative computed tomography (CT) images. The study will also investigate associations between ultrasound measurements and clinical characteristics related to airway management, including difficult tracheal intubation, difficult mask ventilation, trismus, tumor location, and previous radiotherapy

Read the detailed description

Adult patients with oncologic maxillofacial disease scheduled for elective surgery under general anesthesia will be prospectively enrolled.

Before induction of anesthesia, an ultrasound examination of the anterior neck will be performed by a trained anesthesiologist using a predefined measurement protocol. The distance from the skin to the epiglottis (DSE) and the distance from the skin to the hyoid bone (DSHB) will be recorded. Patient positioning and the ultrasound measurement technique will be standardized according to the study protocol.

Corresponding measurements will be obtained from preoperatively available CT examinations by a radiologist using predefined anatomical landmarks and measurement planes. No CT examination will be performed solely for research purposes.

The primary analysis will assess the agreement between ultrasound-based and CT-based DSE measurements. Agreement between ultrasound-based and CT-based DSHB measurements will be assessed as a secondary outcome.

Clinical airway characteristics and perioperative airway management data will be recorded. Difficult tracheal intubation will be evaluated using the Intubation Difficulty Scale (IDS), with an IDS score greater than 5 defining difficult intubation when the scale can be validly applied. Difficult mask ventilation will be classified according to the Han classification.

Patients for whom awake fiberoptic intubation is planned before induction because of a recognized difficult airway, including severe trismus or tumor-related anatomical distortion, will not undergo an attempt at conventional intubation solely for research purposes. These patients will be documented separately as having a pre-recognized difficult airway. IDS-based analyses will be restricted to patients in whom the scale can appropriately be assessed.

The study will not assign treatment or alter the planned airway management. All clinical decisions will remain the responsibility of the treating anesthesiologist.

02

Conditions studied

  • Head and Neck Cancer

Keywords

  • airway ultrasonography
  • difficult ventilation
  • difficult intubation
  • difficult airway management
  • head and neck cancer
  • distance from skin to epiglottis
  • distance from skin to hyoid bone
  • computed tomography
03

In context

Head and Neck Neoplasms

2,409 studies on the registry are indexed under Head and Neck Neoplasms; 562 are open to participants now.

This study's planned enrollment of 30 is below the median of 100 across 456 observational studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

University Hospital Dubrava is the lead sponsor of 43 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with oncologic disease of the maxillofacial or head and neck region, scheduled for elective surgery under general anesthesia with planned airway management requiring tracheal intubation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults aged 18 years or older.
  2. Patients with oncologic disease of the maxillofacial or head and neck region. 3. Patients scheduled for elective surgery under general anesthesia with planned airway management requiring tracheal intubation.

4. Availability of a preoperative CT examination suitable for the predefined airway measurements.

5. Written informed consent to participate.

Exclusion criteria

Exclusion Criteria:

  1. Age below 18 years.
  2. Emergency surgery.
  3. Inability to obtain interpretable ultrasound measurements.
  4. CT images unsuitable for the predefined anatomical measurements.
  5. Refusal to participate or inability to provide informed consent.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with oncologic maxillofacial disease
06

What researchers measure

Primary outcomes

  1. Agreement between ultrasound and CT measurements of DSE

    Agreement between ultrasound measured and CT measured distance from skin to epiglottis

    Time frame: Perioperative

Secondary outcomes

  1. Agreement between ultrasound-measured and CT-measured distance from the skin to the hyoid bone (DSHB)

    Time frame: Perioperative

  2. Association between ultrasound-measured DSE and difficult tracheal intubation, defined as an Intubation Difficulty Scale (IDS) score greater than 5

    Time frame: Perioperative

  3. Association between ultrasound-measured DSHB and difficult tracheal intubation, defined as an Intubation Difficulty Scale (IDS) score greater than 5

    Time frame: Perioperative

  4. Association between ultrasound-measured DSE and DSHB and difficult mask ventilation classified according to the Han classification

    Time frame: Perioperative

  5. Association between ultrasound-measured DSE and DSHB and preoperative clinical predictors of difficult intubation (maximal interincisal distance, Mallampati score, thyromental distance, neck circumference, neck mobility)

    Time frame: Perioperative

  6. Reproducibility of repeated ultrasound measurements of DSE and DSHB in the predefined subset of the first 10 participants

    Time frame: Perioperative

  7. Association between ultrasound-measured DSE and DSHB and tumor location and previous radiotherapy.

    Time frame: Perioperative

07

Study locations

2 of 2 sites recruiting
  • Universitiy Hospital Dubrava
    Zagreb, City of Zagreb 10000, Croatia
    Recruiting
  • University Hospital Dubrava
    Zagreb, City of Zagreb 10000, Croatia
    Recruiting
    • Marcela Čučković, MD · Contactmmarcec@kbd.hr · 38512902444
    • Marcela Čučković, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant-level data will not be made publicly available. Study results may be disseminated in scientific publications using aggregated data. Data will be handled in accordance with applicable data protection requirements and the approved study protocol.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07910149
Lead sponsor
University Hospital Dubrava
Responsible party
Marcela Čučković (Principal Investigator, University Hospital Dubrava) — Principal investigator
First posted
Nov 2, 2026
Start date
Sep 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Nov 2, 2026

Study contacts

Marcela Čučković
Contact
mmarcec@kbd.hr
38512902444

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion